7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Hirsutism D006628 3 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Mastocytoma D034801 3 associated lipids
Progeria D011371 3 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Hearing Loss D034381 3 associated lipids
Periapical Granuloma D010484 3 associated lipids
Respirovirus Infections D010253 3 associated lipids
Osteitis Deformans D010001 3 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Fu YX et al. Osteoprotegerin influences the bone resorption activity of osteoclasts. 2013 Int. J. Mol. Med. pmid:23563320
Xu L et al. Effects of cell surface α2-3 sialic acid on osteogenesis. 2013 Glycoconj. J. pmid:23519914
Çankaya M et al. The effects of chronic zoledronate usage on the jaw and long bones evaluated using RANKL and osteoprotegerin levels in an animal model. 2013 Int J Oral Maxillofac Surg pmid:23522850
Kwon H et al. Effect of 635 nm irradiation on high glucose-boosted inflammatory responses in LPS-induced MC3T3-E1 cells. 2013 Lasers Med Sci pmid:22699799
Weiss RM et al. Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. 2013 PLoS ONE pmid:23762316
Ding Q and Zhang FQ [Effect of icariin on the expression of receptor activator nuclear factor-κB ligand and osteoprotegerin of human periodontal ligament cells]. 2013 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:23714056
Tecilazich F et al. Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications. 2013 J. Vasc. Surg. pmid:23465172
Ye Z et al. Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease. 2013 Am. J. Hypertens. pmid:23467205
Prati AJ et al. Release of bone markers in immediately loaded and nonloaded dental implants: a randomized clinical trial. 2013 J. Dent. Res. pmid:24158337
Kim HR et al. Serum osteoprotegerin level is associated with degree of arteriovenous fistula stenosis in patients with hemodialysis. 2013 Clin. Nephrol. pmid:24091316
Xiong Q et al. [Effects of recombinant human osteoprotegerin and recombinant RANK protein on the differentiation of osteoclast precursors]. 2013 Zhongguo Gu Shang pmid:23844495
Kovács G et al. [Metabolic differences in healthy first-degree female relatives of type 2 diabetic patients]. 2013 Orv Hetil pmid:24161599
Zhang PF et al. Interrelationship of circulating matrix metalloproteinase-9, TNF-α, and OPG/RANK/RANKL systems in COPD patients with osteoporosis. 2013 COPD pmid:23845033
Riesco M et al. Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures. 2013 Clin. Rheumatol. pmid:23846386
Nehring P et al. Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sex‑specific rs2073618 polymorphism as a risk factor for diabetic foot. 2013 Pol. Arch. Med. Wewn. pmid:23299915
Galeone A et al. Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. 2013 Eur J Cardiothorac Surg pmid:23671202
Xi L et al. OPG/RANK/RANKL axis in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery. 2013 Cardiology pmid:23295350
Steinmetz M et al. Atorvastatin-induced increase in progenitor cell levels is rather caused by enhanced receptor activator of NF-kappaB ligand (RANKL) cell proliferation than by bone marrow mobilization. 2013 J. Mol. Cell. Cardiol. pmid:23295770
Saito K et al. Conditional inactivation of TNFα-converting enzyme in chondrocytes results in an elongated growth plate and shorter long bones. 2013 PLoS ONE pmid:23349978
Kelesidis T et al. Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study. 2013 AIDS Res. Hum. Retroviruses pmid:23351153
Jimi E et al. The RANKL/RANK system as a therapeutic target for bone invasion by oral squamous cell carcinoma (Review). 2013 Int. J. Oncol. pmid:23354319
Pei Z et al. Effect of icariin on cell proliferation and the expression of bone resorption/formation-related markers in human periodontal ligament cells. 2013 Mol Med Rep pmid:24065204
Olivares-Navarrete R et al. Rough titanium alloys regulate osteoblast production of angiogenic factors. 2013 Spine J pmid:23684238
Ney JT et al. Genetic polymorphism of the OPG gene associated with breast cancer. 2013 BMC Cancer pmid:23369128
Milone F et al. Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases. 2013 Biomarkers pmid:23336103
Cao H et al. Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation. 2013 Int. J. Cardiol. pmid:22178057
Zhang ZG et al. Therapeutic effect of aqueous extract from Ecliptae herba on bone metabolism of ovariectomized rats. 2013 Menopause pmid:23096243
Giganti MG et al. Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. 2012 Oct-Dec J. Biol. Regul. Homeost. Agents pmid:23241117
Heitzer E et al. IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. 2012 Nov-Dec Pain Physician pmid:23159968
Nuño-Arana I et al. Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. 2012 Jul-Aug Am. J. Hum. Biol. pmid:22434650
Varsavsky M et al. Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. 2012 Jul-Aug J. Androl. pmid:21903971
Dalezis P et al. Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. 2012 Jan-Feb In Vivo pmid:22210719
Ambroszkiewicz J et al. [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. 2012 Apr-Jun Med Wieku Rozwoj pmid:22971655
Xu S et al. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. 2012 Rheumatol. Int. pmid:22057136
Ermakov S et al. A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma. 2012 Osteoporos Int pmid:22057548
Zhao X et al. hRpn13, a newly identified component of the 19S particle, regulates proliferation, differentiation, and function in the human osteoblast-like cell line MG63. [corrected]. 2012 J. Physiol. Biochem. pmid:22057889
Wang N et al. Reduced bone turnover in mice lacking the P2Y13 receptor of ADP. 2012 Mol. Endocrinol. pmid:22108801
Nakashima T et al. New insights into osteoclastogenic signaling mechanisms. 2012 Trends Endocrinol. Metab. pmid:22705116
Janda K et al. [The relationship between advancement of secondary hyperparathyroidism and selected calcification parameters in peritoneal dialysis patients]. 2012 Prz. Lek. pmid:23750431
Roodman GD Genes associate with abnormal bone cell activity in bone metastasis. 2012 Cancer Metastasis Rev. pmid:22706844
Martínez-Calatrava MJ et al. RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis. 2012 Arthritis Res. Ther. pmid:22709525
Kim H et al. The association between polymorphisms in Wnt antagonist genes and bone response to hormone therapy in postmenopausal Korean women. 2012 Menopause pmid:22668815
Marzaioli V et al. Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes. 2012 Arthritis Rheum. pmid:22674155
Ford ML et al. FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart. 2012 Nephrol. Dial. Transplant. pmid:21750158
Xie H et al. Omentin-1 exerts bone-sparing effect in ovariectomized mice. 2012 Osteoporos Int pmid:21755404
Sun C et al. [Acqusition of full-length gene for rabbit osteoprotegerin]. 2012 Sheng Wu Yi Xue Gong Cheng Xue Za Zhi pmid:22404020
Quan J et al. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma. 2012 Pathology pmid:22406484
Yoon HY et al. Poncirin prevents bone loss in glucocorticoid-induced osteoporosis in vivo and in vitro. 2012 J. Bone Miner. Metab. pmid:22407507
Wen Y et al. Application of eGFP to label human periodontal ligament stem cells in periodontal tissue engineering. 2012 Arch. Oral Biol. pmid:22410147
Vasconcelos AC et al. Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds - histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation. 2012 J. Oral Pathol. Med. pmid:22417074
Zhang L et al. Effect of heat stress on the expression levels of receptor activator of NF-κB ligand and osteoprotegerin in human periodontal ligament cells. 2012 Int Endod J pmid:21899569
Altan BA et al. Metrical and histological investigation of the effects of low-level laser therapy on orthodontic tooth movement. 2012 Lasers Med Sci pmid:21038101
Aronis KN et al. Secretion patterns of circulating osteoprotegerin and response to acute and chronic energy deprivation in young healthy adults. 2012 J. Clin. Endocrinol. Metab. pmid:22563105
Djamiatun K et al. Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. 2012 PLoS Negl Trop Dis pmid:22563509
Galli C et al. Actin cytoskeleton controls activation of Wnt/β-catenin signaling in mesenchymal cells on implant surfaces with different topographies. 2012 Acta Biomater pmid:22564787
Morena M et al. Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients. 2012 PLoS ONE pmid:22567137
Banfi G et al. Osteoprotegerin, RANK and RANKL are not modified by acute exercise in elite rugby players. 2012 J Sports Med Phys Fitness pmid:22525657
Taddei SR et al. Role of CCR2 in orthodontic tooth movement. 2012 Am J Orthod Dentofacial Orthop pmid:22284282
Karieb S and Fox SW Zinc modifies the effect of phyto-oestrogens on osteoblast and osteoclast differentiation in vitro. 2012 Br. J. Nutr. pmid:22289672
Lee JW et al. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells. 2012 J Nat Med pmid:21656335
Wieczorek-Baranowska A et al. Osteocalcin and glucose metabolism in postmenopausal women subjected to aerobic training program for 8 weeks. 2012 Metab. Clin. Exp. pmid:22000586
Ostrowska Z et al. RANKL/RANK/OPG system and bone status in females with anorexia nervosa. 2012 Bone pmid:22001124
Kam WW et al. The 18 kDa translocator protein (peripheral benzodiazepine receptor) expression in the bone of normal, osteoprotegerin or low calcium diet treated mice. 2012 PLoS ONE pmid:22295097
Makras P et al. Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis. 2012 J. Clin. Endocrinol. Metab. pmid:22278426
Stępień E et al. Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjects. 2012 Hypertens. Res. pmid:22278625
Babür C et al. Gingival crevicular fluid levels of osteoprotegerin (OPG) in premenopausal and postmenopausal women with or without chronic periodontitis. 2012 J Dent pmid:22326720
Bataille C et al. Different sympathetic pathways control the metabolism of distinct bone envelopes. 2012 Bone pmid:22326888
Taylor RM et al. CD14- mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst. 2012 Lab. Invest. pmid:22330339
Shen P et al. Expression of osteoprotegerin in placenta and its association with preeclampsia. 2012 PLoS ONE pmid:22952959
Diercke K et al. IL-1β and compressive forces lead to a significant induction of RANKL-expression in primary human cementoblasts. 2012 J Orofac Orthop pmid:22955577
Chen YH et al. Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failure. 2012 PLoS ONE pmid:22957004
Feng G et al. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women. 2012 J. Pediatr. Endocrinol. Metab. pmid:23329761
Hogrefe C et al. Single impact cartilage trauma and TNF-α: interactive effects do not increase early cell death and indicate the need for bi-/multidirectional therapeutic approaches. 2012 Int. J. Mol. Med. pmid:22922824
Pereda GO et al. Inflammatory and bone regulators expression in murine macrophages under exposure of commercial and experimental mineral trioxide aggregate. 2012 Aust Dent J pmid:22924350
Tyagi AM et al. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. 2012 PLoS ONE pmid:22970248
Rashtchizadeh N et al. Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients. 2012 Ther Apher Dial pmid:23190522
Xue Y et al. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. 2012 PLoS ONE pmid:23144698
Nicu EA et al. RCT comparing implants with turned and anodically oxidized surfaces: a pilot study, a 3-year follow-up. 2012 J. Clin. Periodontol. pmid:23151294
Adamczyk T et al. Biomarkers of calcification and atherosclerosis in patients with degenerative aortic stenosis in relation to concomitant coronary artery disease. 2012 Pol. Arch. Med. Wewn. pmid:22237719
Ahmed HH et al. Potential role of leptin against glucocorticoid-induced secondary osteoporosis in adult female rats. 2012 Eur Rev Med Pharmacol Sci pmid:23104664
Zhou YB et al. Insulin resistance induces medial artery calcification in fructose-fed rats. 2012 Exp. Biol. Med. (Maywood) pmid:22238287
Kwon SR et al. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. 2012 Rheumatol. Int. pmid:21833531
Jia P et al. [The effect of ferric ion on the differentiation of osteoclast and bone resorption]. 2012 Zhonghua Yi Xue Za Zhi pmid:23158430
Dieset I et al. Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein. 2012 Schizophr. Res. pmid:22817875
Wang F et al. Icariin enhances the healing of rapid palatal expansion induced root resorption in rats. 2012 Phytomedicine pmid:22818561
Histing T et al. Melatonin impairs fracture healing by suppressing RANKL-mediated bone remodeling. 2012 J. Surg. Res. pmid:20888595
Martínez E et al. Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir. 2012 AIDS pmid:23018438
Thadani U Osteoprotegerin and ST segment myocardial infarction: a novel risk marker but not for routine use at present. 2012 Cardiology pmid:23018624
Rieder P et al. TiNOx coatings increase human primary osteoblasts proliferation independently of the substrate: a short report. 2012 Biomed Mater Eng pmid:23023144
Zhou W and Mei L Effect of autologous bone marrow stromal cells transduced with osteoprotegerin on periodontal bone regeneration in canine periodontal window defects. 2012 Int J Periodontics Restorative Dent pmid:22754911
Jansson AM et al. Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:23023373
Baud'huin M et al. A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22761317
Taylan A et al. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. 2012 BMC Musculoskelet Disord pmid:23025387
Shen C et al. Relation between bone mineral density, bone loss and the risk of cardiovascular disease in a Chinese cohort. 2012 Am. J. Cardiol. pmid:22762713
Dey P et al. Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. 2012 Mol. Endocrinol. pmid:23028063
Luan X et al. Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin. 2012 J. Immunol. pmid:22664871
Song TJ et al. Association of plasma osteoprotegerin levels with stroke severity and functional outcome in acute ischaemic stroke patients. 2012 Biomarkers pmid:23030274
Galli C et al. Effect of surface treatment on cell responses to grades 4 and 5 titanium for orthodontic mini-implants. 2012 Am J Orthod Dentofacial Orthop pmid:22640672
Ramirez-Yanez GO and Symons AL Prostaglandin E2 affects osteoblast biology in a dose-dependent manner: an in vitro study. 2012 Arch. Oral Biol. pmid:22480456
Dalbeth N and McQueen FM Clarification of the modified radiographic damage scoring method for gout. 2012 J. Rheumatol. pmid:22467953

Table of Content